Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis
- PMID: 690441
Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis
Abstract
Leukocyte inhibitory factor (LIF), which was derived from human peripheral blood lymphocytes by stimulation with concanavalin A ad partially purified by Sephadex G-100 gel filtration, inhibited the in vitro spontaneous migration and chemotaxis of human PMN leukocytes as assessed in a Boyden chamber micropore filter assay. The inhibitory activity was attributed to LIF, a principle defined in terms of its inhibition of PMN leukocyte migration from glass capillary tubes since it was preferentially directed to PMN leukocytes as compared to mononuclear leukocytes, exhibited a size comparable to LIF by gel filtration, and was inactivated by diisopropyl fluorophosphate in parallel with LIF. Incubation of PMN leukocytes with LIF released additional inhibitory activity, distinct from LIF, which resembled the neutrophil-immobilizing factor (NIF) by virtue of its approximate m.w. of 4000 by filtration on Sephadex G-25, inactivation by trypsin digestion, and preferential noncytotoxic inhibition of spontaneous migration and chemotaxis of PMN leukocytes as compared to mononuclear leukocytes. Thus LIF inhibits PMN leukocyte migration both by a direct action on the cells and by an amplification pathway that is mediated by low m.w. chemotactic inhibitors similar to NIF.
Similar articles
-
Human leukocyte inhibitory factor (LIF): a lymphocyte mediator with esteratic properties.Fed Proc. 1978 Nov;37(13):2743-7. Fed Proc. 1978. PMID: 710595
-
Human leukocyte inhibitory factor (LIF): two distinct molecular species.J Immunol. 1979 Mar;122(3):1059-61. J Immunol. 1979. PMID: 36430
-
Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).J Immunol. 1975 Apr;114(4):1161-5. J Immunol. 1975. PMID: 1090666
-
Partial characterization of lymphokines that change the surface charge density of human polymorphonuclear leukocytes.Immunobiology. 1982;162(2):141-52. doi: 10.1016/S0171-2985(11)80025-2. Immunobiology. 1982. PMID: 7118152
-
Physiological studies with human leukocyte inhibitory factor.Immunol Ser. 1992;57:373-85. Immunol Ser. 1992. PMID: 1504141 Review.
Cited by
-
Mononuclear cells from patients with the hyperimmunoglobulin E-recurrent infection syndrome produce an inhibitor of leukocyte chemotaxis.J Clin Invest. 1982 May;69(5):1155-63. doi: 10.1172/jci110551. J Clin Invest. 1982. PMID: 7068851 Free PMC article.
-
Modulation of human lymphocyte function by C3a and C3a(70-77).J Exp Med. 1982 Sep 1;156(3):756-65. doi: 10.1084/jem.156.3.756. J Exp Med. 1982. PMID: 7050289 Free PMC article.
-
Isolation of two polypeptides comprising the neutrophil-immobilizing factor of human leucocytes.Immunology. 1983 Jan;48(1):79-86. Immunology. 1983. PMID: 6848456 Free PMC article.
-
Constituents of human neutrophils that mediate enhanced adherence to surfaces: purification and identification as acidic proteins of the specific granules.J Clin Invest. 1980 Jun;65(6):1372-81. doi: 10.1172/JCI109801. J Clin Invest. 1980. PMID: 6251111 Free PMC article.
-
Physiological studies with human leukocyte inhibitory factor.Surv Immunol Res. 1985;4(3):230-7. doi: 10.1007/BF02918676. Surv Immunol Res. 1985. PMID: 3003858 No abstract available.